Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Pizzolo

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Internal and Emergency Medicine|February 23, 2021
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19Walter Ageno, Chiara Cogliati, Martina Perego, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Aldosterone to Renin ratio in a primary care setting: the Bussolengo studyOliviero Olivieri, Alberto Ciacciarelli, Denise Signorelli, et al.
Atherosclerosis Plus|January 16, 2023
Novel protein-truncating variant in the <i>APOB</i> gene may protect from coronary artery disease and adverse cardiovascular eventsGabriele Mango, Nicola Osti, Silvia Udali, et al.
Hypertension (Dallas, Tex. : 1979)|November 18, 2015
Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary AldosteronismSilvia Monticone, Fumitoshi Satoh, Anna S Dietz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2013
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer riskSimonetta Friso, Silvia Udali, Patrizia Guarini, et al.
Experimental Diabetes Research|October 1, 2011
Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery diseaseNicola Martinelli, Roberta Micaglio, Letizia Consoli, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
Exploring the Plasma Fatty Acid Signature of Primary Aldosteronism: Comparison with Essential Hypertension and Longitudinal Therapy EffectsGabriele Mango, Annalisa Castagna, Patrizia Pattini, et al.
Molecular Biosystems|February 8, 2014
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenomaOliviero Olivieri, Daniela Cecconi, Annalisa Castagna, et al.
Clinical Chemistry and Laboratory Medicine|April 14, 2018
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery diseaseOliviero Olivieri, Carmela Chiariello, Nicola Martinelli, et al.
Thrombosis and Haemostasis|September 8, 2004
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosisClaudia Bozzini, Domenico Girelli, Francesco Bernardi, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Internal and Emergency Medicine|February 23, 2021
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19Walter Ageno, Chiara Cogliati, Martina Perego, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Aldosterone to Renin ratio in a primary care setting: the Bussolengo studyOliviero Olivieri, Alberto Ciacciarelli, Denise Signorelli, et al.
Atherosclerosis Plus|January 16, 2023
Novel protein-truncating variant in the <i>APOB</i> gene may protect from coronary artery disease and adverse cardiovascular eventsGabriele Mango, Nicola Osti, Silvia Udali, et al.
Hypertension (Dallas, Tex. : 1979)|November 18, 2015
Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary AldosteronismSilvia Monticone, Fumitoshi Satoh, Anna S Dietz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2013
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer riskSimonetta Friso, Silvia Udali, Patrizia Guarini, et al.
Experimental Diabetes Research|October 1, 2011
Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery diseaseNicola Martinelli, Roberta Micaglio, Letizia Consoli, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
Exploring the Plasma Fatty Acid Signature of Primary Aldosteronism: Comparison with Essential Hypertension and Longitudinal Therapy EffectsGabriele Mango, Annalisa Castagna, Patrizia Pattini, et al.
Molecular Biosystems|February 8, 2014
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenomaOliviero Olivieri, Daniela Cecconi, Annalisa Castagna, et al.
Clinical Chemistry and Laboratory Medicine|April 14, 2018
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery diseaseOliviero Olivieri, Carmela Chiariello, Nicola Martinelli, et al.
Thrombosis and Haemostasis|September 8, 2004
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosisClaudia Bozzini, Domenico Girelli, Francesco Bernardi, et al.
Pageof 9